Donguibogam Evidence Bridge한국어

Grassleaf sweetflag 石菖蒲

Pharmaceutical nameAcori Graminei Rhizoma

Evidence grade: Preclinical onlyauto-proposed · unreviewedSafety signal: Adverse-event literature existsMapping confidence: Strong correspondence

The three axes are assessed independently and are never combined into a single score.

KTKP records the origin species as Acorus gramineus Sol. ex Aiton. It has not yet been cross-checked against the Korean Pharmacopoeia, so the identification confidence is not raised to an official code mapping. The same drug appears under 2 records as name variants. The same source species also yields 1 other separately registered drug(s) (Flabellum ex Acori), which must not be conflated. The name most used for this taxon in current literature is Acorus gramineus. Literature searches for this herb also cover Acorus macrospadiceus, Acori graminei — the same taxon appears under several names. The nomenclatural discussion for this herb was flagged for correction during verification; only the verified facts are shown here, with the details in docs/HERB_NAME_RESEARCH.md.

Tradition · what the text describes

탕액편

The sub-section within this volume has not been verified against the original text yet.

The KTKP traditional materia medica record (M0002000) gives the origin species as Acorus gramineus Sol. ex Aiton, the part used as 뿌리줄기, and the properties as 무독(無毒), 신고(辛苦), 온(溫). It lists 간(肝), 심(心), 위(胃) as the channels entered. The same record cites the Donguibogam (1613) as the source for its indications.

Properties & channel entry: 무독(無毒), 신고(辛苦), 온(溫) · 간(肝), 심(心), 위(胃)

Source species: Acorus gramineus Sol. ex Aiton (뿌리줄기)

Read the original: Korean Medicine Classics DB ↗

Modern · documented evidence

Alzheimer Diseaseevidence for this indication

Evidence grade: Preclinical onlyauto-proposed · unreviewed
  • 2 registered trial(s) exist but no published systematic review or RCT was found. Check whether the research is ongoing or simply unpublished.
  • The indication was derived automatically from the Condition field of 2 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.

Literature

SR 0 · RCT 0 · preclinical 1

No human clinical literature found; 1 preclinical (in vitro/animal) record(s) only.

Query used

We publish the exact query behind these counts so you can reproduce them yourself.

SRC:MED AND ((TITLE_ABS:"Acorus gramineus") OR (TITLE_ABS:"Acorus macrospadiceus") OR (TITLE_ABS:"Acori graminei")) AND TITLE_ABS:"Alzheimer Disease"

Clinical trials

Safety

auto-proposed · unreviewed

  • 4 adverse-event or toxicity record(s) were found. This only flags that literature exists — read the abstracts to decide between "caution" and "harm confirmed".
  • The KTKP record states the following traditional contraindication: 음휴혈허(陰虧血虛), 음허양항(陰虛陽亢)으로 번조(煩躁), 해수(咳嗽), 토혈(吐血), 정활(精滑), 다한(多汗) 자는 복용을 삼가한다.

Adverse-event and toxicity literature

This is not a finding of harm — it lists literature that is retrievable. Read the papers to decide.

Sources

Bridges from here

In formulas
영지원 · 투이통 · 청신해어탕 · 천왕보심단
Related patterns
Heart blood deficiency pattern · Phlegm confounding the orifices of the heart pattern · Kidney qi deficiency pattern